van Puijenbroek AA - Search Results

1

CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.

Appleman LJ, van Puijenbroek AA, Shu KM, Nadler LM, Boussiotis VA. Appleman LJ, et al. Among authors: van puijenbroek aa. J Immunol. 2002 Mar 15;168(6):2729-36. doi: 10.4049/jimmunol.168.6.2729. J Immunol. 2002. PMID: 11884439

2

Induction of immunologic tolerance for allogeneic hematopoietic cell transplantation.

Appleman LJ, Tzachanis D, Grader-Beck T, Van Puijenbroek AA, Boussiotis VA. Appleman LJ, et al. Among authors: van puijenbroek aa. Leuk Lymphoma. 2002 Jun;43(6):1159-67. doi: 10.1080/10428190290026213. Leuk Lymphoma. 2002. PMID: 12152983 Review.

3

cAMP inhibits both Ras and Rap1 activation in primary human T lymphocytes, but only Ras inhibition correlates with blockade of cell cycle progression.

Grader-Beck T, van Puijenbroek AA, Nadler LM, Boussiotis VA. Grader-Beck T, et al. Among authors: van puijenbroek aa. Blood. 2003 Feb 1;101(3):998-1006. doi: 10.1182/blood-2002-06-1665. Epub 2002 Sep 19. Blood. 2003. PMID: 12393539 Free article.

4

Differential localization and function of ADP-ribosylation factor-6 in anergic human T cells: a potential marker for their identification.

Tzachanis D, Appleman LJ, Van Puijenbroek AA, Berezovskaya A, Nadler LM, Boussiotis VA. Tzachanis D, et al. Among authors: van puijenbroek aa. J Immunol. 2003 Aug 15;171(4):1691-6. doi: 10.4049/jimmunol.171.4.1691. J Immunol. 2003. PMID: 12902467

5

Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics.

Appleman LJ, Tzachanis D, Grader-Beck T, van Puijenbroek AA, Boussiotis VA. Appleman LJ, et al. Among authors: van puijenbroek aa. J Mol Med (Berl). 2001;78(12):673-83. doi: 10.1007/s001090000180. J Mol Med (Berl). 2001. PMID: 11434720 Review.

6

Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells.

Tzachanis D, Freeman GJ, Hirano N, van Puijenbroek AA, Delfs MW, Berezovskaya A, Nadler LM, Boussiotis VA. Tzachanis D, et al. Among authors: van puijenbroek aa. Nat Immunol. 2001 Dec;2(12):1174-82. doi: 10.1038/ni730. Nat Immunol. 2001. PMID: 11694881

7

Active Rap1, a small GTPase that induces malignant transformation of hematopoietic progenitors, localizes in the nucleus and regulates protein expression.

Lafuente EM, Iwamoto Y, Carman CV, van Puijenbroek AA, Constantine E, Li L, Boussiotis VA. Lafuente EM, et al. Among authors: van puijenbroek aa. Leuk Lymphoma. 2007 May;48(5):987-1002. doi: 10.1080/10428190701242341. Leuk Lymphoma. 2007. PMID: 17487743

8

RIAM, an Ena/VASP and Profilin ligand, interacts with Rap1-GTP and mediates Rap1-induced adhesion.

Lafuente EM, van Puijenbroek AA, Krause M, Carman CV, Freeman GJ, Berezovskaya A, Constantine E, Springer TA, Gertler FB, Boussiotis VA. Lafuente EM, et al. Among authors: van puijenbroek aa. Dev Cell. 2004 Oct;7(4):585-95. doi: 10.1016/j.devcel.2004.07.021. Dev Cell. 2004. PMID: 15469846 Free article.

9

Cytokine signal transduction in P19 embryonal carcinoma cells: regulation of Stat3-mediated transactivation occurs independently of p21ras-Erk signaling.

van Puijenbroek AA, van der Saag PT, Coffer PJ. van Puijenbroek AA, et al. Among authors: van der saag pt. Exp Cell Res. 1999 Sep 15;251(2):465-76. doi: 10.1006/excr.1999.4576. Exp Cell Res. 1999. PMID: 10471331

10

Transcriptional regulation of the junB promoter: analysis of STAT-mediated signal transduction.

Coffer P, Lutticken C, van Puijenbroek A, Klop-de Jonge M, Horn F, Kruijer W. Coffer P, et al. Oncogene. 1995 Mar 2;10(5):985-94. Oncogene. 1995. PMID: 7898939

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters